NCT00002288View on ClinicalTrials.gov

The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (1)

27709

Glaxo Wellcome Inc, Research Triangle Park

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002288 - The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous System | Biotech Hunter | Biotech Hunter